Bone Changes After 3 Mo of Lactation: Influence of Calcium Intake, Breast-milk Output, and Vitamin D-receptor Genotype
Overview
Affiliations
Factors influencing the change in bone mineral after 3 mo of lactation were investigated in 47 breast-feeding mothers, 11 formula-feeding mothers, and 22 nonpregnant, nonlactating control subjects. At 6-8 wk postpartum, the breast-feeding group had a mean (+/-SD) calcium intake of 34.8+/-13.2 mmol/d and breast-milk volume, calcium concentration, and calcium output of 0.865+/-0.230 L/d, 7.41+/-1.25 mmol/L, and 6.41+/-2.00 mmol/d, respectively. There was no relation between calcium intake and any breast-milk variable. Dual-energy X-ray absorptiometry of the whole body, spine, hip, and forearm was performed at 0.5 and 3 mo. There were significant decreases in bone mineral content at the spine (3.96%; 95% CI: 4.86%, 3.06%), femoral neck (2.39%; 95% CI: 3.61%, 1.17%), total hip (1.51%; 95% CI: 2.45%, 0.60%), and whole body (0.86%; 95% CI: 1.29%, 0.43%) in breast-feeding mothers but not in formula-feeding mothers or nonpregnant, nonlactating women. These changes were not related to calcium intake, breast-milk calcium concentration, vitamin D-receptor genotype, postpartum weight change, or use of the progesterone-only contraceptive pill. After adjustment for bone area, breast-milk volume and height were identified as significant predictors at the spine, such that greater decreases were associated with taller mothers (P = 0.007) and those with greater breast-milk volume (P = 0.001). This finding suggests that the marked bone mineral changes observed in breast-feeding mothers represented a physiologic response to lactation that was independent of dietary calcium supply.
Kongwattanakul K, Duangkum C, Ngamjarus C, Lumbiganon P, Cuthbert A, Weeks J Cochrane Database Syst Rev. 2024; 11:CD007079.
PMID: 39560075 PMC: 11574946. DOI: 10.1002/14651858.CD007079.pub4.
Shakeri Jooybari B, Nasri Nasrabadi F, Esteghamati A Biol Trace Elem Res. 2024; .
PMID: 39557818 DOI: 10.1007/s12011-024-04436-6.
Effective strategies for pregnancy and lactation-associated osteoporosis: teriparatide use in focus.
Ali D, Khan A, Brandi M Endocrine. 2024; 86(2):459-469.
PMID: 39008200 DOI: 10.1007/s12020-024-03946-6.
Ferreira L, Tirapeli K, Silva C, Goldberg T Int Breastfeed J. 2023; 18(1):68.
PMID: 38111005 PMC: 10729562. DOI: 10.1186/s13006-023-00607-8.
Karbasi S, Moradi Binabaj M, Khorasanchi Z, Bideh M, Zarban A, Bahrami A J Health Popul Nutr. 2023; 42(1):40.
PMID: 37149671 PMC: 10163718. DOI: 10.1186/s41043-023-00381-7.